Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | GABRP | O00591 | 1/20 | 0.58 |
| ▸ | GABRD | O14764 | 1/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.58 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.58 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.58 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.58 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.58 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.58 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.58 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.58 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.58 |
| ▸ | GABRE | P78334 | 1/20 | 0.58 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.58 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.58 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.58 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.58 |
| ▸ | RORB | Q92753 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516764 | 1.00 | RECQL (1.00) | RECQLGABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL8835389 | 0.98 | RECQL (0.97) | RECQLGABRPGABRDGABRA1GABRB1 | |
| Hydrazine SCHEMBL11776632 | 0.98 | RECQL (0.97) | RECQLGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL3253860 | 0.89 | RECQL (0.80) | RECQLGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL9540049 | 0.89 | RECQL (0.79) | RECQLALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL2829388 | 0.88 | RECQL (0.78) | RECQLGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL8296814 | 0.88 | RECQL (0.78) | RECQLGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11624724 | 0.87 | RECQL (0.77) | RECQLALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL11842389 | 0.87 | RECQL (0.77) | RECQLGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL29849818 | 0.86 | RECQL (0.75) | RECQLGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062390-A1 | CONTINUOUS FLOW SYNTHESIS OF LORAZEPAM | PURDUE RESEARCH FOUNDATION | 2026-03-05 | — | — | US | claimed |
| WO-2024036115-A1 | CONTINUOUS FLOW SYNTHESIS OF LORAZEPAM | PURDUE RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | WO | claimed |
| CN-110606839-B | Green synthesis method of polysubstituted quinazoline derivative | 南方医科大学 | 2021-10-08 | — | — | CN | claimed |
| CN-112028844-A | Preparation method of lorazepam intermediate | 北京益民药业有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-111707752-A | HPLC detection method of chlordiazepam related substances | 山东新华制药股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| EP-3470491-A1 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | The Chemours Company FC, LLC (US) | 2019-04-17 | — | — | EP | claimed |
| EP-2410032-B1 | Phosphorus-containing stabilizers for fluoroolefins | CHEMOURS CO FC LLC (US) | 2018-11-14 | — | — | EP | claimed |
| US-20170362483-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | THE CHEMOURS COMPANY FC, LLC | 2017-12-21 | — | — | US | claimed |
| EP-2420546-B1 | Terephthalate stabilizers for fluoroolefins | CHEMOURS CO FC LLC (US) | 2017-04-26 | — | — | EP | claimed |
| EP-2057247-B1 | ASCORBIC ACID STABILIZERS FOR FLUOROOLEFINS | DU PONT (US) | 2016-04-13 | — | — | EP | claimed |
| WO-2008027511-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027594-A2 | PHENOL STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027515-A2 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027512-A2 | FUNCTIONALIZED PERFLUOROPOLYETHER STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027596-A2 | BENZOPHENONE DERIVATIVE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027519-A1 | OXETANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027514-A1 | TERPENE, TERPENOID, AND FULLERENE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2008027513-A2 | ARYL-ALKYL ETHER, POLYOXYALKYLATED AROMATIC, AND ALKYLATED AROMATIC STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | claimed |
| US-4511510-A | PHTHALIMIDOGLYCINE, HYDRAZINE | RAVIZZA S.P.A. (IT) | 1985-04-16 | — | — | US | claimed |
| US-4010153-A | Preparation of chiral 1,4-benzodiazepin-2-one-derivatives by reaction of (s)-α-amino acid chloride hydrochlorides etc. | CRC COMPAGNIA DI RICERCA CHIMICA S.A. (CH) | 1977-03-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062390-A1 | CONTINUOUS FLOW SYNTHESIS OF LORAZEPAM | GRIK4, GRIK5, POLM | RECQL 449/4885GABRP 99/4885GABRD 115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.